Aug 26, 2026 05:16PM
Aug 26, 2026 05:16PM
Jul 21, 2026 04:06PM
Jul 21, 2026 04:05PM
Mar 6, 2026 07:45AM
Jan 7, 2026 04:06PM
Jan 7, 2026 04:00PM Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
Dec 17, 2025 04:05PM
Dec 17, 2025 04:05PM
Dec 12, 2025 10:47AM
Nov 19, 2025 09:45AM
Sep 16, 2025 07:00AM
Sep 16, 2025 07:00AM
Aug 13, 2025 04:05PM Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates
Jul 9, 2025 08:00AM
Mar 20, 2025 04:05PM
Jan 7, 2025 07:04AM
Jan 7, 2025 07:00AM
Dec 17, 2024 08:00AM
Dec 12, 2024 08:00AM
Dec 12, 2024 08:00AM Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
Nov 13, 2024 04:05PM
Oct 15, 2024 08:01AM
Oct 15, 2024 08:00AM
Oct 15, 2024 08:00AM
Sep 12, 2024 04:06PM
Sep 12, 2024 04:05PM
Aug 6, 2024 04:05PM Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates
Jul 31, 2024 04:05PM
May 7, 2024 04:05PM
Mar 6, 2024 08:00AM
Mar 1, 2024 08:00AM
Feb 20, 2024 08:00AM
Feb 20, 2024 08:00AM
Dec 12, 2023 08:00AM Immuneering Corporation (IMRX) Announces FDA Clearance of IND Application for Phase 1/2a Trial of IMM-6-415
Dec 12, 2023 08:00AM
Mar 6, 2023 04:05PM
Mar 6, 2023 04:05PM
Sep 30, 2022 06:52AM
Sep 30, 2022 06:50AM
Sep 30, 2022 06:50AM
Sep 2, 2022 08:09AM Immuneering Corporation (IMRX) Submits FDA IND Application for Phase 1/2a Trial of IMM-1-104
Sep 2, 2022 08:09AM
Sep 2, 2022 08:09AM
Mar 31, 2022 04:05PM
Mar 10, 2022 06:34AM
Mar 10, 2022 06:30AM
Mar 10, 2022 06:30AM
Jan 18, 2022 06:50AM Immuneering Corporation (IMRX) Appoints Diana F. Hausman to its Board
Jan 18, 2022 06:50AM

330,004 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All